Clinical Report: Correction on Cardiovascular Mortality in RA from 1999 to 2023

Overview

This report addresses corrections made to the original article on cardiovascular mortality associated with rheumatoid arthritis (RA) in U.S. adults from 1999 to 2023. Key updates include corrected figure captions that clarify stratification by gender and urbanization.

Background

Rheumatoid arthritis is a chronic inflammatory disease that significantly increases cardiovascular risk among affected individuals. Understanding trends in cardiovascular mortality related to RA is crucial for healthcare providers to implement effective management strategies. Recent data indicate that while RA continues to confer excess cardiovascular disease risk, the incidence of comorbidities may be decreasing due to improved treatment approaches.

Data Highlights

No numerical data is provided in the correction article.

Key Findings

• The original article contained incorrect figure captions regarding mortality rates.
• Figure 3 now correctly stratifies CVD and RA-related CVD mortality by gender.
• Figure 4 has been updated to reflect deaths related to CVD and RA-related CVD stratified by urbanization.
• Figure 5 now accurately presents age-adjusted mortality rates stratified by race.
• Overall trends in cardiovascular mortality related to RA have been updated to reflect these corrections.

Clinical Implications

Clinicians should be aware of the corrected data to accurately interpret trends in cardiovascular mortality among RA patients. This understanding is essential for tailoring preventive strategies and improving patient outcomes in this high-risk population.

Conclusion

The corrections made to the original article enhance the clarity and accuracy of the data presented on cardiovascular mortality in RA. Ongoing monitoring and research are necessary to further understand the implications of these trends.

Related Resources & Content

1. Ye Jiang et al., Front. Cardiovasc. Med., 2026 -- Trends in cardiovascular mortality related to rheumatoid arthritis among U.S. adults, 1999–2023
2. sentara — Cardiovascular Risk in Rheumatoid Arthritis: What Clinicians Need to Know
3. Clinical Rheumatology — Evaluating Cardiovascular Risks in Axial Spondyloarthritis: A Comprehensive Review
4. European Journal of Preventive Cardiology — Temporal trend and attributable risk factors of cardiovascular disease burden for adults 55 years and older in 204 countries/territories from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021
5. conexiant — Oxidative Balance, Inflammation Linked to RA Mortality
6. Cardiovascular Risk in Rheumatoid Arthritis: What Clinicians Need to Know
7. Evaluating Cardiovascular Risks in Axial Spondyloarthritis: A Comprehensive Review
8. Temporal trend and attributable risk factors of cardiovascular disease burden for adults 55 years and older in 204 countries/territories from 1990 to 2021
9. Data Access - Vital Statistics Online
10. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
11. Cardiovascular Outcomes and Vascular Surrogate Markers in Rheumatoid Arthritis Patients Treated With Anti-Tumour Necrosis Factor (TNF) Therapy: A Systematic Review and Meta-Analysis - PubMed